Associated Papers
Emden: A novel method integrating graph and transformer representations for predicting the effect of mutations on clinical drug response.
Liu Z et al.
Computers in Biology and Medicine, 2023
Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells.
Hamid AB et al.
Cancers, 2020
The Immunogenic Potential of Recurrent Cancer Drug Resistance Mutations: An In Silico Study.
Punta M et al.
Frontiers in Immunology, 2020
33133066 (PubMed )
Supplement: Table_1.xlsx › Resistance-no-BCR-ABL1
Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer.
Clarke PA et al.
Oncogene, 2019
Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.
Kiel C et al.
Molecular Systems Biology, 2014
24803665 (PubMed )
Supplement: MSB-10-5-727-s13.xls › energies
ERK inhibition overcomes acquired resistance to MEK inhibitors.
Hatzivassiliou G et al.
Molecular Cancer Therapeutics, 2012
Select a paper to view details